Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of Two LY4064809 Formulations in Healthy Adult Participants
NCT07339735Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2026
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tersolisib (2 arms), sponsored by Eli Lilly and Company. Primary endpoints: Maximum Concentration and Area Under the Concentration Versus Time Curve. Started Jan 2026; status: completed.
02
Drugs
tersolisib
Beyond the preview
Go deeper on NCT07339735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07339735.